J Gynecol Oncol.  2009 Mar;20(1):8-10. 10.3802/jgo.2009.20.1.8.

Gynecological cancer in Indonesia

• Aziz MF

• KMID: 2055641
• DOI: http://doi.org/10.3802/jgo.2009.20.1.8

Abstract

To overview the status of gynecologic cancer in Indonesia. Information regarding Indonesia obtained from World Bank Report and Statistical Yearbook of Indonesia 2007, epidemiological data obtained from Histopathological Data of Cancer in Indonesia 2002, Department of Health-Registry Body of Indonesian Specialist of Pathology Association-Indonesian Cancer Society; Various Hospitals in big Cities in Indonesia. Indonesia is an Archipelago with a total area of 1,922,570.00 km2, the population is 222,192,000 (2006), the fourth world rank. Female is 49.86% with life expectancy 69 years. Gross National Product per Capita is 690.00 USD. Histopathological report in 2002 revealed that cervical cancer, ovarian cancer and uterine cancer were the most frequent cancer among female, which were the first (2,532 cases), the third (829 cases) and the eighth (316 cases) rank respectively. The peak age for cervical, uterine and ovarian cancer was 45-54 years. HPV 16, 18 were found in 82% of invasive cervical. Data from various academic hospitals in 2007 showed that cervical cancer is the most common malignancy followed by ovary, uterus, vulva and vagina. Five-year survival rate of stage I, II, III, IV cervical cancer were 50%, 40%, 20%, and 0% respectively. Overall five-year survival rate of carcinoma of the ovary was 54.8%. If sub-classified by stage, five-year survival rate are 94.3%, 75.0%, 31%, and 11.7% for stage I, II, III, and IV respectively. Five-year disease-free survival rate of endometrial cancer was 71.9%. Indonesia is the biggest Archipelago with a dense population but the income per capita still low (poor country). The most common gynecologic cancer is cervical cancer, followed by ovarian and uterine cancer. These cancers are included in top ten cancers in Indonesia. HPV 16, 18 were the most cause of cervical cancer. The five-year survival rates are comparable with world report.

Keyword

Gynecologic neoplasms; Epidemiology

MeSH Terms

Disease-Free Survival
Endometrial Neoplasms
Female
Genital Neoplasms, Female
Gross Domestic Product
Human papillomavirus 16
Humans
Indonesia
Life Expectancy
Ovarian Neoplasms
Ovary
Specialization
Survival Rate
United Nations
Uterine Cervical Neoplasms
Uterine Neoplasms
Uterus
Vagina
Vulva

Reference

1. Ferlay J, Bray F, Pisani P, Parkin D. GLOBOCAN 2002. Cancer Incidence, mortality and prevalence worldwide. 2004. version 2.0. Lyon: IARC Press;IARC CancerBase No.5.

2. Domingo EJ, Noviani R, Noor MR, Ngelangel CA, Limpaphayom KK, Thuan TV, et al. Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam. Vaccine. 2008. 26:Suppl 12. M71–M79.

3. de Boer MA, Vet JN, Aziz MF, Cornain S, Purwoto G, van den Akker BE, et al. Human Papillomavirus type 18 and other risk factors for cervical cancer in Jakarta, Indonesia. Int J Gynecol Cancer. 2006. 16:1809–1814.

4. International fight against cervical cancer. Female Cancer Program 2005. cited 2009 Feb 2. Available from: http://www.femalecancerprogram.org/FCP/.